Statutory instrument laid in the House of Lords and House of Commons, on Monday, 7 February 2022 by Secretary Sajid Javid on behalf of the Department of Health and Social Care. It was approved by the House of Commons on Wednesday, 9 March 2022. It was made on Tuesday, 22 March 2022.

Human Medicines (Coronavirus and Influenza) (Amendment) Regulations

Secondary information

Type: Statutory instrument
Reference: SI 2022/358; 2022/
Session: 2021-22
Coming into force: Wednesday, 23 March 2022
Procedure: Affirmative
Laying authority: Act
Laid in draft: Yes
Referred to: DL
Related items: Secondary Legislation Scrutiny Committee thirty-first report.
Tuesday, 1 March 2022
Parliamentary committees
House of Lords; Draft Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2022; draft Human Medicines (Amendments Relating to the Early Access to Medicines Scheme) Regulations 2022
Tuesday, 8 March 2022
Committee proceedings
House of Commons; Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2022
Monday, 14 March 2022
Parliamentary proceedings
House of Lords; Medicines
Wednesday, 9 March 2022
Parliamentary proceedings
House of Commons; Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2022
Thursday, 17 March 2022
Parliamentary proceedings
House of Lords
Contains explanatory memorandum: Yes
Contains impact assessment: Yes
Notes: Explanatory memorandum withdrawn and replaced 17 February 2022 (UC 69).
Subjects: Advertising Licensing Marketing Vaccination Influenza Coronavirus
Legislation: Medicines and Medical Devices Act 2021; Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2022
Library location: Commons Library: UP 964 2021-22; UC 69 2021-22
Link: View this Statutory instrument on www.legislation.gov.uk